Specificity and Selectivity of a Modified Radioligand Method for Estimating the Binding Activity of β1 Adrenergic Receptors in Human T Lymphocytes
- 作者: Smolyakova E.V.1, Skoblov Y.S.2, Skoblova N.A.2, Agapova O.Y.3, Ambatiello L.G.1, Klimova A.A.1, Kuznetsova T.V.1, Masenko V.P.1, Nistor S.Y.3, Rvacheva A.V.3, Chazova I.E.1, Zykov K.A.4,3
-
隶属关系:
- National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Healthcare of the Russian Federation
- Research Institute of Pulmonology, Federal Medical and Biological Agency of Russia
- 期: 卷 45, 编号 2 (2019)
- 页面: 129-134
- 栏目: Article
- URL: https://bakhtiniada.ru/1068-1620/article/view/229174
- DOI: https://doi.org/10.1134/S1068162019020134
- ID: 229174
如何引用文章
详细
A radioligand-based method was proposed for quantifying the binding activity of β1-adrenergic receptors (ARs) on the surface of human T lymphocytes. Using the transfected HEK293 cell lines expressing β1-AR (ADL-7A) and β2-AR (A2R9) as a model, the conditions for [125I]cyanopindolol reliable detection of specific ligand binding to β1-adrenergic receptors at the level of 1–1.5 fmol per 1 million cells were selected. The real possibility of performing this analysis for clinical studies was shown by the example of human T lymphocytes.
作者简介
E. Smolyakova
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
编辑信件的主要联系方式.
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 121552
Yu. Skoblov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 117997
N. Skoblova
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 117997
O. Agapova
Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 127473
L. Ambatiello
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 121552
A. Klimova
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 121552
T. Kuznetsova
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 121552
V. Masenko
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 121552
S. Nistor
Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 127473
A. Rvacheva
Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 127473
I. Chazova
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 121552
K. Zykov
Research Institute of Pulmonology, Federal Medical and Biological Agency of Russia; Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Healthcare of the Russian Federation
Email: smolyakovak@mail.ru
俄罗斯联邦, Moscow, 115682; Moscow, 127473
补充文件
